H. Lee Moffitt Cancer Center and Research Institute clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 539 studies whose lead sponsor is H. Lee Moffitt Cancer Center and Research Institute. 74 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 7, 2026.
Keep track of what changes. Save the H. Lee Moffitt Cancer Center and Research Institute studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions H. Lee Moffitt Cancer Center and Research Institute leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 539. Browse all 539 →
- Rituximab and Zanubrutinib in Patients With Indolent B-cell LymphomasRecruitingNCT06350318Phase 2
- SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesRecruitingNCT04923542Phase 1/2
- Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)RecruitingNCT06144606Phase 2
- Genomically Guided Radiation Therapy in the Management of Triple Negative Breast CancerRecruitingNCT05528133Phase 2
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesRecruitingNCT07194044Phase 1
- Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)RecruitingNCT06305676
- Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCLRecruitingNCT06553872Phase 2
- Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCRecruitingNCT06745882Phase 2
- Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)RecruitingNCT06423950
- Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian CancerRecruitingNCT05316129Phase 1
- Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid TumorsRecruitingNCT06047977Phase 1
- Modifying Diet to Improve Gut MicrobiomeNot yet recruitingNCT03924778Not applicable
- Intermittent Fasting for PancreatitisNot yet recruitingNCT04760847Not applicable
- Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLCRecruitingNCT05681780Phase 1
- Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell TherapyRecruitingNCT05757219Phase 2
- Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and ScreeningRecruitingNCT06745895Not applicable
- Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaRecruitingNCT04741997Early Phase 1
- Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid TumorsRecruitingNCT07487168Phase 1
- Study of Screening Brain MRIs in Stage IV Breast CancerRecruitingNCT05115474Phase 2
- Remote Exercise and Nutritional Prehabilitation for Pancreatic CancerRecruitingNCT06423963Not applicable
- PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)Not yet recruitingNCT07638150Not applicable
- Evaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryRecruitingNCT07686250Phase 2
- Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of a Validated Smoking Cessation Intervention for Spanish-speaking SmokersNot yet recruitingNCT07754448Not applicable
- Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)RecruitingNCT06560398Not applicable
- Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and OsteosarcomaRecruitingNCT07725380Phase 1/2
- Digoxin Medulloblastoma StudyRecruitingNCT06701812Phase 2
- Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDSRecruitingNCT05746442Not applicable
- Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic TherapyRecruitingNCT06660355Phase 2
- Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology AgentsRecruitingNCT06963346Phase 1
- Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMDRecruitingNCT07694986Phase 2
- Phase II Study of Systemic Screening in Pathologic Node Positive Breast CancerRecruitingNCT06833502Phase 2
- Clinical Trial of CD40L-augmented TIL for Patients With Advanced MelanomaRecruitingNCT06961357Phase 1/2
- Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell CarcinomaRecruitingNCT04975152Phase 1
- Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer SurvivorsRecruitingNCT07447635Not applicable
- Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPCRecruitingNCT07476001Phase 2
- Phase III Trial of Brain MRI Surveillance in Stage IV Breast CancerRecruitingNCT07357298Phase 3
- Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell LymRecruitingNCT06760156Phase 2
- Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCCRecruitingNCT06137274Phase 2
- Generating Novel Therapeutic Strategies Based on Evolutionary Tumor BoardRecruitingNCT04343365
- Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung CancerRecruitingNCT05665504
- Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal CancerRecruitingNCT06497569Not applicable
- BCL2i CLAG-M in R/R Acute Myeloid LeukemiaRecruitingNCT06660368Phase 2
- Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced MelanomaRecruitingNCT06295159Phase 2
- Avapritinib With Decitabine in Patients With SM-AHNRecruitingNCT06327685Phase 1
- Adaptive Therapy of Vismodegib in Advanced Basal Cell CarcinomaRecruitingNCT05651828Early Phase 1
- Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant TherapyRecruitingNCT06435351Early Phase 1
- Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCCRecruitingNCT06553885Phase 2
- Pembrolizumab for Advanced Cutaneous Sarcomas Not Including AngiosarcomaRecruitingNCT07007273Phase 2
- Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic LymphomaRecruitingNCT07030400
- Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)RecruitingNCT07047885Phase 1